- Home
- MRNA vs O Comparison
MRNA vs O Comparison
Compare MRNA & O Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | O |
|---|---|---|
| Founded | 2010 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 51.8B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MRNA | O |
|---|---|---|
| Price | $241.80 | $56.38 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 23 | 25 |
| Target Price | ★ $123.61 | $65.63 |
| AVG Volume (30 Days) | ★ 15.0M | 7.0M |
| Earning Date | 11-06-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 5.87% |
| EPS Growth | ★ 21.77 | 19.39 |
| EPS | N/A | ★ 0.70 |
| Revenue | ★ $19,263,000,000.00 | $5,749,377,000.00 |
| Revenue This Year | $8.09 | $0.17 |
| Revenue Next Year | $16.06 | $4.69 |
| P/E Ratio | ★ N/A | $79.21 |
| Revenue Growth | 4.29 | ★ 9.07 |
| 52 Week Low | $22.28 | $53.15 |
| 52 Week High | $242.29 | $67.94 |
Technical Indicators
Market Signals| Indicator | MRNA | O |
|---|---|---|
| Relative Strength Index (RSI) | 64.66 | 44.27 |
| Support Level | $45.39 | $53.15 |
| Resistance Level | N/A | $63.15 |
| Average True Range (ATR) | 16.80 | 0.81 |
| MACD | 0.03 | 0.43 |
| Stochastic Oscillator | 70.17 | 63.45 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About O Realty Income Corporation
Realty Income owns roughly 15,600 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in all 50 states and Puerto Rico and are leased to nearly 1,800 tenants from 92 industries. Recent acquisitions have added industrial, gaming, office, manufacturing, and distribution properties, which make up roughly 20% of revenue.